-
1
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
-
Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678.
-
(2007)
Lancet
, vol.369
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
-
2
-
-
17844373254
-
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
-
Lakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
-
(2005)
JAMA
, vol.293
, pp. 2126-2130
-
-
Lakovou, I.1
Schmidt, T.2
Bonizzoni, E.3
-
3
-
-
20044366366
-
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
-
Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-953.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 947-953
-
-
Ong, A.T.1
Hoye, A.2
Aoki, J.3
-
4
-
-
0141765805
-
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
-
Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
-
(2003)
N Engl J Med
, vol.349
, pp. 1315-1323
-
-
Moses, J.W.1
Leon, M.B.2
Popma, J.J.3
-
5
-
-
9144249927
-
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
-
Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
-
(2004)
N Engl J Med
, vol.350
, pp. 221-231
-
-
Stone, G.W.1
Ellis, S.G.2
Cox, D.A.3
-
6
-
-
33847723010
-
Unanswered questions - Drug-eluting stents and the risk of late thrombosis
-
Maisel WH. Unanswered questions - Drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007;356:981-984.
-
(2007)
N Engl J Med
, vol.356
, pp. 981-984
-
-
Maisel, W.H.1
-
8
-
-
33845319222
-
BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents
-
Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;4812:2584-2591.
-
(2006)
J Am Coll Cardiol
, vol.4812
, pp. 2584-2591
-
-
Pfisterer, M.1
Brunner-La Rocca, H.P.2
Buser, P.T.3
-
9
-
-
33847741037
-
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents
-
Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997.
-
(2007)
N Engl J Med
, vol.356
, pp. 989-997
-
-
Spaulding, C.1
Daemen, J.2
Boersma, E.3
-
10
-
-
34147126986
-
Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents
-
Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433-1439.
-
(2007)
Circulation
, vol.115
, pp. 1433-1439
-
-
Serruys, P.W.1
Daemen, J.2
-
11
-
-
34548395921
-
Late incomplete apposition after drug-eluting stent implantation: Incidence and potential for adverse clinical outcomes
-
Siqueira DA, Abizaid AA, Costa JD, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28:1304-1309.
-
(2007)
Eur Heart J
, vol.28
, pp. 1304-1309
-
-
Siqueira, D.A.1
Abizaid, A.A.2
Costa, J.D.3
-
12
-
-
33745233024
-
Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk
-
Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 193-202
-
-
Joner, M.1
Finn, A.V.2
Farb, A.3
-
13
-
-
33644872364
-
-
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175.
-
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175.
-
-
-
-
15
-
-
37849049464
-
SPIRITs buoyed with new XIENCE V data: Bests Taxus in head-to-head study
-
Presented at the, at
-
Stone G. SPIRITs buoyed with new XIENCE V data: Bests Taxus in head-to-head study. Presented at the American College of Cardiology Conference' 2007. Last accessed on May8, 2007 at: http://www.theheart.org/article/778115.do
-
(2007)
American College of Cardiology Conference' 2007. Last accessed on May8
-
-
Stone, G.1
|